SOLIQS is a leader in drug delivery with marketed products and a proven track record in enhancing the bioavailability of poorly soluble compounds using its platform technologies Meltrex®.

SOLIQS will take all efforts to provide customized solutions and give you consultative support to your situation.

SOLIQS Technology Platform Offers:

• Novel oral dosage forms for compounds with solubility challenges or that require specifically designed release profiles
• Improved clinical profiles (safety, efficacy) and patient compliance
• Reducing pill burden to patients
• Minimized food effect and/or gastric irritation
• Reduced intra- and interpatient variability
• Significant reduction in dose while maintaining therapeutic efficacy
• Increased R&D productivity and throughput
• Solvent free process with GRAS approved exipients

SOLIQS provides "Solid Solutions for Insoluble Substances"®.